22 Dec Phosphodiesterase type 5 inhibitors and the risk of melanoma skin cancer
Posted at 11:42h
in
Lian Y, Yin H, Pollak MN, Carrier S, Platt RW, Suissa S, Azoulay L. Phosphodiesterase type 5 inhibitors and the risk of melanoma skin cancer. Eur Urol. 2016 Nov;70(5):808-815.